Elekta (OTCMKTS:EKTAY) Shares Gap Down – Should You Sell?

Elekta AB (OTCMKTS:EKTAY)’s share price gapped down before the market opened on Monday . The stock had previously closed at $5.9950, but opened at $5.76. Elekta shares last traded at $5.76, with a volume of 249 shares.

Analyst Ratings Changes

EKTAY has been the subject of several research reports. Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 16th. UBS Group began coverage on Elekta in a report on Wednesday, September 3rd. They issued a “sell” rating for the company. Three research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Reduce”.

Elekta Stock Performance

The stock has a 50 day simple moving average of $5.06 and a two-hundred day simple moving average of $5.04. The company has a market capitalization of $2.11 billion, a price-to-earnings ratio of 81.73 and a beta of 1.04. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.05 and a quick ratio of 0.82.

Elekta (OTCMKTS:EKTAY) last issued its earnings results on Wednesday, November 26th. The company reported $0.07 earnings per share for the quarter. The business had revenue of $427.85 million for the quarter, compared to analyst estimates of $436.91 million. Elekta had a return on equity of 12.06% and a net margin of 1.62%. As a group, analysts anticipate that Elekta AB will post 0.36 earnings per share for the current year.

About Elekta

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.